InsidersTradesSigma
Track the 成都先导 share price and the full management transaction log of the company, a publicly traded company based in China. Shares are listed on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 成都先导 has logged 2 reports. Market capitalisation: €10.5bn. The latest transaction was disclosed on 11 August 2021 (Sale). Among the most active insiders: 拉萨经济技术开发区华博医疗器械有限公司. Every trade is openly available.
2
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€15m
2 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 16,438 of 28,733 companies
47.9
score / 100
Value27
Quality69
FCF yld0.5%
Earn yld1.0%
EV/EBITDA59.8x
ROE8.3%
Gross mgn54%
Net mgn21%
Debt/EBITDA1.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 11 August 2021
Declarations2 total
2,294,970 sharesA股XSHGSSE:173000004641980380
1,496,273 sharesA股XSHGSSE:173000004642039400
2 of 2 declarations
About 成都先导
Chengdu Xian Dao is a company operating in the healthcare and pharmaceutical sector, listed on the XSHG market. It focuses on research and development of innovative solutions in the pharmaceutical field.